文献速递产科

剖宫产术后使用利多卡因贴剂:随机对照试验的荟萃分析

Lidocaine patches after cesarean delivery: a meta-analysis of randomized controlled trials.
PubMed 文献 · Am J Obstet Gynecol MFM · 2025-11-13

该荟萃分析纳入3项随机对照试验共219例妊娠,比较剖宫产术后利多卡因贴剂与安慰剂贴剂的效果。利多卡因贴剂在术后12、24、36小时视觉模拟评分法疼痛评分显著降低,48和72小时疼痛评分、阿片类药物消耗及不良反应与安慰剂相似。作者认为利多卡因贴剂可考虑作为剖宫产术后多模式镇痛策略的一部分。

要点

  • 利多卡因贴剂较安慰剂显著降低剖宫产术后12、24、36小时VAS疼痛评分。
  • 48和72小时VAS疼痛评分、阿片类药物消耗及不良反应两组相似。
  • 作者认为利多卡因贴剂可考虑作为剖宫产术后多模式镇痛策略的一部分。

核心结论

  • 剖宫产术后使用利多卡因贴剂与12、24、36小时疼痛评分显著降低相关,48和72小时疼痛评分、阿片类药物消耗及不良反应与安慰剂相似。
  • 基于这些数据,作者认为利多卡因贴剂可考虑作为剖宫产术后多模式镇痛策略的一部分。

研究设计与样本

  • 随机对照试验的荟萃分析,纳入所有比较剖宫产术后利多卡因贴剂与安慰剂的随机对照试验。
  • 共分析3项随机对照试验,包括219例妊娠。
  • 纳入的随机对照试验质量为中等,随机对照试验间存在一些临床异质性。

主要发现

  • 利多卡因贴剂组与安慰剂贴剂组相比,12小时VAS疼痛评分分别为1.58与2.24(P值=.0006)。
  • 24小时VAS疼痛评分分别为1.8与2.4(P值<.0001)。
  • 36小时VAS疼痛评分分别为0.48与1.68(P值<.00001)。
  • 48和72小时VAS评分、阿片类药物消耗及不良反应两组相似。

关键数值与推荐

  • 主要结局为术后24小时通过视觉模拟评分法测量的疼痛。
  • 次要结局为12、36、48和72小时通过视觉模拟评分法测量的疼痛、阿片类药物消耗及不良反应。
  • 汇总测量以相对危险度或均数差报告,带95%置信区间。

临床怎么用

  • 作者认为,基于这些数据,利多卡因贴剂可考虑作为剖宫产术后多模式镇痛策略的一部分。

局限性

  • 纳入的随机对照试验质量为中等。
  • 随机对照试验间存在一些临床异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the impact of lidocaine patches use after cesarean delivery on postoperative pain and document adverse reactions STUDY ELIGIBILITY CRITERIA: Meta-analysis of randomized controlled trials (RCTs). We included all RCTs comparing lidocaine patch use after cesarean delivery with placebo. The primary outcome was pain at 24 hours postoperative measured through Visual Analogue Scale (VAS). Secondary outcomes were: pain at 12, 36, 48 hours and 72 hours measured through VAS scale; opioid consumption; and adverse reactions. The summary measures were reported as relative risk (RR) or as mean difference (MD) with 95% of confidence interval (CI). RESULTS: Three RCTs, including 219 pregnancies, were analyzed. The quality of the RCTs included was moderate. Overall, there was some clinical heterogeneity among RCTs. Lidocaine patches, compared to the placebo patches, were associated with a significant reduction in VAS pain score at 12 hours (1.58 vs 2.24, P value=.0006), 24 hours (1.8 vs 2.4, P value< .0001) and 36 hours (0.48 vs 1.68 P value<.00001), respectively. Lidocaine patches, compared with placebo, was associated with similar VAS scores at 48 and 72 hours, as well as similar opioid consumption and adverse reactions. CONCLUSION: The use of lidocaine patches after cesarean delivery is associated with a significant decrease in pain scores at 12, 24 and 36 hours, as well as similar pain scores at 48 and 72 hours, opioid consumption, and adverse reactions. Based on these data, the use of lidocaine patches may be considered as part of a multimodal analgesia strategy after cesarean delivery.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Parisi N, Petrecca A, Bender W, et al. Lidocaine patches after cesarean delivery: a meta-analysis of randomized controlled trials. Am J Obstet Gynecol MFM. 2025. PMID: 41241094. doi:10.1016/j.ajogmf.2025.101832

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。